Full-Life Technologies
China
- Shanghai
- 05/01/2024
- Series B
- $47,300,000
Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiopharmaceutical company with operations in Belgium, Germany, and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development.
- Industry Pharmaceutical Manufacturing
- Website https://www.full-life.com/
- LinkedIn https://www.linkedin.com/company/full-life-technologies/about/
Related People
Lanny SunFounder
United States -
Boston, Massachusetts
Experienced entrepreneur with strong track record in building global Life Science & Deep Technology companies.
Iceotope | $26,000,000 | (May 15, 2026)
Harken Sweets | Undisclosed Amount | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Ranger AI | $8,400,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
Novella | $21,000,000 | (May 15, 2026)
Flick | $6,000,000 | (May 15, 2026)
Synthetic | $10,000,000 | (May 14, 2026)
SwishX | $2,200,000 | (May 14, 2026)
Urologic Health | $11,000,000 | (May 14, 2026)